Dr Reddys
Recent Highlights
All Stories for Dr Reddys
Sensex surges over 350 points in early trade; Nifty climbs 114.85 points, tops 14,900
•Dr Reddy's was the top gainer in the Sensex pack, followed by ONGC, HDFC, IndusInd Bank, ICICI Bank, Sun Pharma and Kotak Bank
Dr Reddy's expects first lot of COVID-19 vaccine Sputnik V from RDIF by May-end
•A senior executive from Dr Reddy's said the vaccine will be imported in a frozen condition, maintaining a temperature of -18 to -22 degrees Celsius
As race to COVID-19 vaccine heats up, a look at major jabs, development and clinical trials underway
Fp Staff •According to WHO, there are 48 COVID-19 vaccine candidates are undergoing clinical evaluation, of which eleven are at late-stage trials, whereas, 164 candidate vaccines are in preclinical evaluation
Never spoke of vaccinating entire country, says Centre; initial findings of Chennai case did not necessitate trial stoppage: ICMR
Fp Staff •Meanwhile, Dr Reddy's Laboratories Ltd announced the commencement of adaptive phase 2/3 clinical trials for Russia's COVID-19 vaccine Sputnik V in India
India doesn't need Pfizer COVID-19 shot; vaccine should be available by Feb-March: Harsh Vardhan
Tech2 News Staff •The health minster said that no state will be given preferential treatment and the distribution of vaccines will be equitable.
COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority
•Stating that everything is being decided by experts with a scientific point of view, the Union health minister expressed confidence that the COVID-19 vaccine will be ready in the next three to four months
First batch of Sputnik V vaccine likely to reach Kanpur medical college for phase 2,3 trials by next week
•As many as 180 volunteers have registered for the trials and the ethics committee of the college has also given permission, said college principal RB Kamal
DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
Tech2 News Staff •RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.
COVID-19 recoveries continue to surpass new cases; next two-and-a-half month period crucial says Harsh Vardhan
Fp Staff •The health ministry also said on Friday that India has one of the lowest COVID-19 deaths per million population in the world, with less than 1,000 fatalities registered daily since 4 October,
Dr Reddy's asked to resubmit phase 2,3 trial application for Russia's Sputnik V COVID-19 vaccine by DCGI
Tech2 News Staff •Dr Reddy's trials will have to be first assessed in a small group of volunteers to study its efficacy before it can be tested on a larger population.